Altox

Database / Pharmaceutical impurity

Pharmaceutical impurity

Ozagrel Impurity 35

Ozagrel Impurity 35 is listed in the pharmaceutical impurity collection under CAS 7560-50-1. Its represented structure has formula C11H10O3 and a calculated molecular weight of 190.20 g/mol.

2D chemical structure

O O O

Chemical identity

Catalog name
Ozagrel Impurity 35
Common name
Ozagrel Impurity 35
Chemical name
methyl 3-(4-formylphenyl)prop-2-enoate
CAS
7560-50-1
SMILES
COC(=O)C=Cc1ccc(C=O)cc1
InChI
InChI=1S/C11H10O3/c1-14-11(13)7-6-9-2-4-10(8-12)5-3-9/h2-8H,1H3
InChIKey
KVXMLLMZXPRPNG-UHFFFAOYSA-N
Associated API
Ozagrel

Record ID: Aa0b8a1b8a725

Computed properties

C11H10O3 Molecular formula
190.198 g/molMolecular weight
190.063 DaMonoisotopic exact mass
43.37 ŲTopological polar surface area
1.6853 Calculated LogP (Wildman–Crippen)
52.8795 cm³/molMolar refractivity (Wildman–Crippen)
3 countHydrogen-bond acceptors
0 countHydrogen-bond donors

Descriptors are calculated from the displayed SMILES. Calculated LogP is not a measured partition coefficient or a pH-specific LogD.

Molecular descriptor profile

Descriptor radar

Mol. weight LogP TPSA HBA HBD Rotatable 25 50 75 100

Structural feature counts

0 1 2 3 Count H-bond acceptors H-bond donors Rotatable bonds Rings Aromatic rings Stereo centers

Element composition

C H O 0 3 6 9 Number of atoms

Radar scale: 0–100 percentile within 25,771 distinct represented structures in this release, using the midpoint rank for ties. Larger values indicate a higher descriptor rank, not greater safety or toxicity. Element counts include hydrogen and combine isotopes under each element.

Radar values and percentile reference
DescriptorValuePercentile
Molecular weight190.19814.92
Calculated LogP (Wildman–Crippen)1.685336.71
Topological polar surface area43.3725.37
Hydrogen-bond acceptors333.13
Hydrogen-bond donors011.28
Rotatable bonds (strict)337.08

Complete molecular descriptors

PropertyCalculated valueUnit / type
Molecular formulaC11H10O3dimensionless
Molecular weight190.198g/mol
Monoisotopic exact mass190.063Da
Topological polar surface area43.37Ų
Calculated LogP (Wildman–Crippen)1.6853dimensionless
Molar refractivity (Wildman–Crippen)52.8795cm³/mol
Hydrogen-bond acceptors3count
Hydrogen-bond donors0count
Rotatable bonds (strict)3count
Heavy atoms14count
Heteroatoms3count
Rings1count
Aromatic rings1count
Aliphatic rings0count
Saturated rings0count
Aromatic heterocycles0count
Aliphatic heterocycles0count
Saturated heterocycles0count
Aromatic carbocycles1count
Aliphatic carbocycles0count
Fraction of sp³ carbon atoms0.0909fraction
Formal charge0e
Disconnected components1count
Isotopically specified atoms0count
Potential atom stereocenters0count
Unspecified atom stereocenters0count
Spiro atoms0count
Bridgehead atoms0count
Labute approximate surface area82.0031Ų
Valence electrons72count
Radical electrons0count
Bertz complexity349.3003index
Balaban J2.7288index

Ring categories overlap and should not be summed. No toxicity result, PDE, HBEL or acceptable intake is inferred from these descriptors.

Toxicological services and resources for Ozagrel Impurity 35

Qualification and safety assessment of Ozagrel Impurity 35

Explore toxicological qualification of Ozagrel Impurity 35 and ICH M7 mutagenic impurity assessment of Ozagrel Impurity 35 for evaluation of this impurity in its pharmaceutical context.

Where data gaps need to be addressed, resources include read-across assessment for Ozagrel Impurity 35 and acceptable intake and limit justification for Ozagrel Impurity 35. The relevant approach depends on the available evidence, exposure and duration of use.

Related Altox services and technical resources

Identity sources and calculation method

Identifiers originate from the source catalogues and available public identity records. InChI and InChIKey on this page are generated from the displayed SMILES. RDKit validation checks the molecular representation; it does not independently verify every catalogue assignment.

Discuss an assessment for Ozagrel Impurity 35

Explore Altox services and software through the Altox Pharma-Hub.